John Doyle Sells 16,656 Shares of Marsh & McLennan Companies (NYSE:MRSH) Stock

Marsh & McLennan Companies, Inc. (NYSE:MRSH) CEO John Doyle sold 16,656 shares of the company’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the sale, the chief executive officer directly owned 116,811 shares in the company, valued at $18,889,506.81. This trade represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Marsh & McLennan Companies Stock Up 2.4%

NYSE MRSH opened at $161.13 on Friday. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11. Marsh & McLennan Companies, Inc. has a 1 year low of $156.60 and a 1 year high of $233.50. The firm has a market cap of $77.84 billion, a price-to-earnings ratio of 20.14, a PEG ratio of 2.29 and a beta of 0.62.

Marsh & McLennan Companies (NYSE:MRSH) last posted its quarterly earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.21 by $0.08. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The firm had revenue of $7.30 billion for the quarter. The firm’s quarterly revenue was up 7.6% compared to the same quarter last year. On average, analysts anticipate that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current year.

Institutional Investors Weigh In On Marsh & McLennan Companies

Several institutional investors and hedge funds have recently bought and sold shares of MRSH. Solstein Capital LLC bought a new stake in Marsh & McLennan Companies during the fourth quarter worth about $25,000. Asset Dedication LLC bought a new stake in Marsh & McLennan Companies during the first quarter worth about $25,000. SHP Wealth Management bought a new stake in Marsh & McLennan Companies during the fourth quarter worth about $26,000. KERR FINANCIAL PLANNING Corp bought a new stake in Marsh & McLennan Companies during the fourth quarter worth about $27,000. Finally, Golden State Wealth Management LLC bought a new stake in Marsh & McLennan Companies during the fourth quarter worth about $27,000. Institutional investors own 87.99% of the company’s stock.

Analyst Upgrades and Downgrades

MRSH has been the topic of several research reports. Piper Sandler decreased their price objective on shares of Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating on the stock in a report on Tuesday, May 26th. Morgan Stanley decreased their price objective on shares of Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating on the stock in a report on Monday, April 6th. Mizuho decreased their price objective on shares of Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating on the stock in a report on Monday, April 13th. JPMorgan Chase & Co. decreased their price target on shares of Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating on the stock in a research note on Thursday, April 9th. Finally, Barclays decreased their price target on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 8th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Marsh & McLennan Companies currently has an average rating of “Hold” and a consensus price target of $203.56.

About Marsh & McLennan Companies

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.